Valeant, Par End Patent Suit Over Colitis Treatment
Par Pharmaceuticals Inc. reached a settlement Monday in a patent infringement suit brought by Valeant Pharmaceuticals International and Cosmo Pharmaceuticals Ltd. in Delaware federal court over Par's attempt to make a...To view the full article, register now.
Already a subscriber? Click here to view full article